Publications by authors named "Jonas Demeulemeester"

Single-cell multi-omics methods enable the study of cell state diversity, which is largely determined by the interplay of the genome, epigenome, and transcriptome. Here, we describe Gtag&T-seq, a genome-and-transcriptome sequencing (G&T-seq) protocol of the same single cells that omits whole-genome amplification (WGA) by using direct genomic tagmentation (Gtag). Gtag drastically decreases the cost and improves coverage uniformity at single-cell and pseudo-bulk levels compared to WGA-based G&T-seq.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates various methods for whole genome amplification in the analysis of somatic mutations, specifically copy number variants (CNVs), in human brain tissue.
  • Three techniques are compared: PicoPLEX, primary template-directed amplification (PTA), and droplet MDA, revealing distinct characteristics of each method in terms of amplification efficiency and chimeric profiles.
  • The research confirms that a significant portion of brain cells (20.6%) exhibit CNVs, emphasizing the need for careful selection of amplification methods and reference genomes when studying genomic variations in both healthy and diseased brains.
View Article and Find Full Text PDF
Article Synopsis
  • Oncogenes can become activated through mechanisms like enhancer hijacking and mutations that generate new enhancers or promoters, helping researchers understand variations in noncoding cancer genomes.
  • A new mechanism is identified where the loss of an intronic element in the FTO gene causes abnormal expression of the IRX3 oncogene in T cell acute lymphoblastic leukemia (T-ALL).
  • The study suggests that 'promoter tethering' helps keep oncogenes inactive by linking them to non-functioning parts of the genome, which may act as a safeguard against tumor development.
View Article and Find Full Text PDF

Subclonal reconstruction algorithms use bulk DNA sequencing data to quantify parameters of tumor evolution, allowing an assessment of how cancers initiate, progress and respond to selective pressures. We launched the ICGC-TCGA (International Cancer Genome Consortium-The Cancer Genome Atlas) DREAM Somatic Mutation Calling Tumor Heterogeneity and Evolution Challenge to benchmark existing subclonal reconstruction algorithms. This 7-year community effort used cloud computing to benchmark 31 subclonal reconstruction algorithms on 51 simulated tumors.

View Article and Find Full Text PDF

In the mammalian liver, hepatocytes exhibit diverse metabolic and functional profiles based on their location within the liver lobule. However, it is unclear whether this spatial variation, called zonation, is governed by a well-defined gene regulatory code. Here, using a combination of single-cell multiomics, spatial omics, massively parallel reporter assays and deep learning, we mapped enhancer-gene regulatory networks across mouse liver cell types.

View Article and Find Full Text PDF
Article Synopsis
  • - Transmissible cancers like bivalve transmissible neoplasia (BTN) can spread between marine organisms, particularly affecting species like the common cockle (Cerastoderma edule) along the Atlantic coasts of Europe and Africa.
  • - Researchers examined over 6,800 cockles, diagnosed 390 cases of BTN tumors, and analyzed genomic variation in 61 tumors, confirming the presence of two BTN lineages with links to blood cell origins.
  • - The study found significant genomic instability in the BTN tumors, including whole-genome duplications and mutations, and suggested a long history of clonal evolution in these transmissible cancers.
View Article and Find Full Text PDF

Neuropeptides and peptide hormones are ancient, widespread signaling molecules that underpin almost all brain functions. They constitute a broad ligand-receptor network, mainly by binding to G protein-coupled receptors (GPCRs). However, the organization of the peptidergic network and roles of many peptides remain elusive, as our insight into peptide-receptor interactions is limited and many peptide GPCRs are still orphan receptors.

View Article and Find Full Text PDF

The presence of somatic mutations, including copy number variants (CNVs), in the brain is well recognized. Comprehensive study requires single-cell whole genome amplification, with several methods available, prior to sequencing. We compared PicoPLEX with two recent adaptations of multiple displacement amplification (MDA): primary template-directed amplification (PTA) and droplet MDA, across 93 human brain cortical nuclei.

View Article and Find Full Text PDF

Purpose: Failure to respond to induction chemotherapy portends a poor outcome in childhood acute lymphoblastic leukemia (ALL) and is more frequent in T-cell ALL (T-ALL) than B-cell ALL. We aimed to address the limited understanding of clinical and genetic factors that influence outcome in a cohort of patients with T-ALL induction failure (IF).

Methods: We studied all cases of T-ALL IF on two consecutive multinational randomized trials, UKALL2003 and UKALL2011, to define risk factors, treatment, and outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines how intratumour heterogeneity (ITH) impacts lung cancer evolution, leading to immune evasion and therapy resistance using data from non-small cell lung cancer patients.
  • It analyzes RNA and whole-exome sequencing from 354 tumours, revealing significant transcriptomic diversity that contributes to phenotypic variation and influences the selection process during tumour evolution.
  • The research identifies key mechanisms like allele-specific expression and RNA-editing enzyme activity that connect the genome and transcriptome, affecting metastasis potential and the overall evolution of lung cancer.
View Article and Find Full Text PDF

Lung adenocarcinomas (LUADs) display a broad histological spectrum from low-grade lepidic tumors through to mid-grade acinar and papillary and high-grade solid, cribriform and micropapillary tumors. How morphology reflects tumor evolution and disease progression is poorly understood. Whole-exome sequencing data generated from 805 primary tumor regions and 121 paired metastatic samples across 248 LUADs from the TRACERx 421 cohort, together with RNA-sequencing data from 463 primary tumor regions, were integrated with detailed whole-tumor and regional histopathological analysis.

View Article and Find Full Text PDF

Single-cell RNA sequencing studies have suggested that total mRNA content correlates with tumor phenotypes. Technical and analytical challenges, however, have so far impeded at-scale pan-cancer examination of total mRNA content. Here we present a method to quantify tumor-specific total mRNA expression (TmS) from bulk sequencing data, taking into account tumor transcript proportion, purity and ploidy, which are estimated through transcriptomic/genomic deconvolution.

View Article and Find Full Text PDF
Article Synopsis
  • Development of primary mediastinal B-cell lymphoma (PMBL) is influenced by unique genomic changes, particularly copy-neutral loss of heterozygosity (CN-LOH), setting it apart from other B-cell cancers.
  • A study found that 91% of PMBL cases exhibited extensive CN-LOH regions, affecting multiple chromosomes, with the largest segments contributing to an average 9.9% loss of genetic diversity.
  • The findings reveal that CN-LOH may play a significant role in the progression of PMBL, potentially serving as a second mutational hit that affects crucial driver genes like MHC I and B2M.
View Article and Find Full Text PDF

The infinite sites model of molecular evolution posits that every position in the genome is mutated at most once. By restricting the number of possible mutation histories, haplotypes and alleles, it forms a cornerstone of tumor phylogenetic analysis and is often implied when calling, phasing and interpreting variants or studying the mutational landscape as a whole. Here we identify 18,295 biallelic mutations, where the same base is mutated independently on both parental copies, in 559 (21%) bulk sequencing samples from the Pan-Cancer Analysis of Whole Genomes study.

View Article and Find Full Text PDF

Understanding how enhancers drive cell-type specificity and efficiently identifying them is essential for the development of innovative therapeutic strategies. In melanoma, the melanocytic (MEL) and the mesenchymal-like (MES) states present themselves with different responses to therapy, making the identification of specific enhancers highly relevant. Using massively parallel reporter assays (MPRAs) in a panel of patient-derived melanoma lines (MM lines), we set to identify and decipher melanoma enhancers by first focusing on regions with state-specific H3K27 acetylation close to differentially expressed genes.

View Article and Find Full Text PDF
Article Synopsis
  • Most cancers, including hepatocellular carcinoma (HCC), often develop through genomic changes that promote tumor growth, with specific focus on the effects of the Hepatitis B virus (HBV).
  • HBV integrates its DNA into the tumor genome, leading to significant alterations like chromosomal fusions and deletions, contributing to cancer development in about 8% of HCC cases.
  • These mutations usually happen early in liver cancer evolution, sometimes up to 20 years before a cancer is diagnosed, highlighting the need to study liver cancer genomes for potential HBV-related changes.
View Article and Find Full Text PDF

During eukaryotic transcription elongation, RNA polymerase II (RNAP2) is regulated by a chorus of factors. Here, we identified a common binary interaction module consisting of TFIIS N-terminal domains (TNDs) and natively unstructured TND-interacting motifs (TIMs). This module was conserved among the elongation machinery and linked complexes including transcription factor TFIIS, Mediator, super elongation complex, elongin, IWS1, SPT6, PP1-PNUTS phosphatase, H3K36me3 readers, and other factors.

View Article and Find Full Text PDF

A substantial fraction of the human genome displays high sequence similarity with at least one other genomic sequence, posing a challenge for the identification of somatic mutations from short-read sequencing data. Here we annotate genomic variants in 2,658 cancers from the Pan-Cancer Analysis of Whole Genomes (PCAWG) cohort with links to similar sites across the human genome. We train a machine learning model to use signals distributed over multiple genomic sites to call somatic events in non-unique regions and validate the data against linked-read sequencing in an independent dataset.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists discovered that some cancer cells can become resistant to treatment because of special cells that don’t die off, called persister cells or minimal residual disease (MRD).
  • In patients with melanoma, they found that a type of stem cell appears during treatment and helps the cancer survive in ways that aren't always genetic.
  • By stopping these stem cells from growing, they were able to slow down the return of cancer in experiments, showing that the mix of cells in MRD can change how well cancer treatments work.
View Article and Find Full Text PDF

Genomic sequence variation within enhancers and promoters can have a significant impact on the cellular state and phenotype. However, sifting through the millions of candidate variants in a personal genome or a cancer genome, to identify those that impact -regulatory function, remains a major challenge. Interpretation of noncoding genome variation benefits from explainable artificial intelligence to predict and interpret the impact of a mutation on gene regulation.

View Article and Find Full Text PDF
Article Synopsis
  • * Analysis of 2,658 whole-genome sequences reveals that 95.1% of samples show distinct subclonal expansions that evolve through branching relationships, highlighting the complexity within tumors.
  • * This study identifies specific patterns of driver mutations and other genetic alterations in different cancer types, offering valuable insight into tumor evolution and a resource for understanding subclonal events across cancers.
View Article and Find Full Text PDF

STAT1 gain-of-function (GOF) is a primary immunodeficiency typically characterized by chronic mucocutaneous candidiasis (CMC), recurrent respiratory infections, and autoimmunity. Less commonly, also immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX)-like syndromes with CMC, and combined immunodeficiency without CMC have been described. Recently, our group and others have shown that different mutation-specific mechanisms underlie STAT1 GOF , including faster nuclear accumulation (R274W), and reduced mobility (R321, N574I) to near immobility in the nucleus (T419R) upon IFNγ stimulation.

View Article and Find Full Text PDF
Article Synopsis
  • - Chromosomal instability in cancer leads to significant changes in chromosome number and structure, allowing for diverse somatic copy number alterations (SCNAs) that drive tumor evolution across various cancer types.
  • - An analysis of over 1,400 tumor samples revealed that 37% showed parallel evolutionary events affecting the same key genes, with most recurrent chromosomal losses happening before the whole-genome doubling event.
  • - Furthermore, certain SCNAs were found frequently in metastatic samples, indicating that chromosomal instability facilitates ongoing genetic changes that aid in the progression and diversity of tumors.
View Article and Find Full Text PDF